​

Prime Medicine Ownership | Who Owns Prime Medicine?

OverviewForecastRevenueFinancialsChart

Prime Medicine Ownership Summary

Prime Medicine is owned by 45.96% institutional investors, 24.07% insiders, and 29.97% retail investors. Sherbrooke park advisers is the largest institutional shareholder, holding 0% of PRME shares. ARK Genomic Revolution is the top mutual fund, with 1.91% of its assets in Prime Medicine shares.

PRME Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPrime Medicine45.96%24.07%29.97%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sherbrooke park advisers---
Point72 asset management---
Metlife investment management---
Exoduspoint capital management, lp---
Massmutual trust co fsb/adv---
Jane street group---
Us bancorp \de\---
Creative planning---
Aristides capital---
National bank of canada /fi/---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sherbrooke park advisers---
Point72 asset management---
Metlife investment management---
Exoduspoint capital management, lp---
Massmutual trust co fsb/adv---
Jane street group---
Us bancorp \de\---
Creative planning---
Aristides capital---
National bank of canada /fi/---

Top Buyers

HolderShares% AssetsChange
Federated hermes---6.00
Massmutual trust co fsb/adv---104.00
Allworth financial lp---141.00
Us bancorp \de\---202.00
Point72 (difc)---309.00

Top Sellers

HolderShares% AssetsChange
Westwood group---883.13K
Walleye capital---403.74K
Susquehanna fundamental investments---144.72K
Exoduspoint capital management, lp---131.73K
Jane street group---101.76K

Sold Out

HolderChange
Federated hermes-6.00
Massmutual trust co fsb/adv-104.00
Allworth financial lp-141.00
Us bancorp \de\-202.00
Point72 (difc)-309.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025124-4.62%60,152,185-4.70%451.64%61-12.86%359.38%
Dec 31, 202413211.86%64,335,371-6.37%531.64%7235.85%326.67%
Sep 30, 2024118-4.07%68,711,038-0.26%571.72%53-24.29%30-
Jun 30, 20241235.13%68,888,4713.34%571.42%7011.11%30-9.09%
Mar 31, 202411710.38%66,659,13737.23%632.24%6310.53%3317.86%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Genomic Revolution2.50M1.91%86.27K
ARK Genomic Revolution ETF2.32M1.77%-
ARK Disruptive Innovation Full Composite2.23M1.70%-237.53K
Vanguard US Total Market Shares ETF2.16M1.65%-
Vanguard Total Stock Mkt Idx Inv2.10M1.60%-
iShares Russell 2000 ETF1.44M1.09%705.00
Nikko AM ARK Disruptive Innovation A USD1.31M1.00%-
T. Rowe Price Small-Cap Value1.30M0.99%-279.00
Nikko AM ARK Pstv Chg Innovt P JPY Acc1.26M0.96%-
US Small-Cap Growth II Equity Comp1.13M0.86%-15.60K

Recent Insider Transactions

DateNameRoleActivityValue
May 20, 2025Brudnick Richard Chief Business OfficerBuy$23.79K
May 21, 2025LEE ANN L. Chief Technical OfficerBuy$113.00K
May 21, 2025Reine Allan Chief Executive OfficerBuy$147.15K
Feb 15, 2024NELSEN ROBERT Buy$20.00M
Feb 15, 2024ARCH Venture Partners XII, LLC-Buy$20.00M

Insider Transactions Trends

DateBuySell
2025 Q23-
2025 Q1--
2024 Q4--
2024 Q2--
2024 Q13-

PRME Ownership FAQ

Who Owns Prime Medicine?

Prime Medicine shareholders are primarily institutional investors at 45.96%, followed by 24.07% insiders and 29.97% retail investors. The average institutional ownership in Prime Medicine's industry, Biotech Stocks , is 63.96%, which Prime Medicine falls below.

Who owns the most shares of Prime Medicine?

Prime Medicine’s largest shareholders are Sherbrooke park advisers (0 shares, 0%), Point72 asset management (0 shares, 0%), and Metlife investment management (0 shares, 0%). Together, they hold 0% of Prime Medicine’s total shares outstanding.

Does Blackrock own Prime Medicine?

BlackRock is not among the top 10 institutional shareholders of Prime Medicine.

Who is Prime Medicine’s biggest shareholder by percentage of total assets invested?

Sherbrooke park advisers is Prime Medicine’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Prime Medicine shares, valued at 0$.

Who is the top mutual fund holder of Prime Medicine shares?

ARK Genomic Revolution is the top mutual fund holder of Prime Medicine shares, with 1.91% of its total shares outstanding invested in 2.5M Prime Medicine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools